نتایج جستجو برای: letrozole

تعداد نتایج: 1593  

2018
Zhu Yu Xiaojing Guo Yicheng Jiang Lei Teng Jinwu Luo Pengfei Wang Yunsheng Liang Haitian Zhang

BACKGROUND In patients with hormone receptor-positive postmenopausal of early stage breast cancer, adjuvant endocrine monotherapies include letrozole, anastrozole, exemestane, toremifene and tamoxifen. But the optimum regimen remains controversial. METHODS PubMed, Cochrane Database and ClinicalTrials.gov were systematically reviewed of abstract for randomized-controlled trials (RCTs) to asses...

2015
Xihe Zhao Lei Liu Kai Li Wusheng Li Li Zhao Huawei Zou

The third-generation aromatase inhibitors (AIs: anastrozole, letrozole, and exemestane) have now become standard adjuvant endocrine treatment for postmenopausal estrogen receptor-positive breast cancer complementing chemotherapy and surgery. Because of the absence of direct head-to-head comparisons of these AIs, an indirect comparison is needed for individual treatment choice. In this network s...

2015
Lendelle Raymond Nikita Rayani Grace Polson Kylie Sikorski Ailin Lian Melissa A. VanAlstine-Parris

Vorozole and letrozole are third-generation aromatase (cytochrome P450 19A1) inhibitors. [(11)C]-Vorozole can be used as a radiotracer for aromatase in living animals but when administered by IV, it collects in the liver. Pretreatment with letrozole does not affect the binding of vorozole in the liver. In search of finding the protein responsible for the accumulation of vorozole in the liver, f...

Journal: : 2023

Polycystic ovary syndrome is a common cause of an ovulatory infertility. Drugs like Aromatase inhibitors, Human menopausal gonadotropin, used for ovulation induction. The aim this study was carried out to compare the therapeutic effects gonadotropin hormone versus oral ovarian stimulating agents. A prospective randomized controlled clinical trial in Salahdeen general hospital Tikrit from 1st Fe...

Journal: :Pakistan Journal of Medical and Health Sciences 2023

Aim: To compare the efficacy of letrozole and clomiphene citrate in women having anovulatory infertility. Study design: Randomized Controlled Trial. Place duration study: 16th October 2020 to 15th September 2021 Department Obstetrics & Gynecology, Shahida Islam Medical Complex Lodhran. Methods: In our study 112 patients between ages 18 40 years with anovulation were included. Patients H/O p...

Journal: :Minerva ginecologica 2012
L Nahid K Sirous

AIM Ovulation dysfunction is one of the most common causes of reproductive failure in infertile couples. The prevalence of this disorder in infertile women is about 30 to 40%. Polycystic ovary syndrome is a common disease that is closely related to ovulation dysfunction and 7% of women of childbearing age are afflicted with it. Ovulation induction is a way to treat infertility in PCOS which is ...

Journal: :The New England journal of medicine 2014
Richard S Legro Robert G Brzyski Michael P Diamond Christos Coutifaris William D Schlaff Peter Casson Gregory M Christman Hao Huang Qingshang Yan Ruben Alvero Daniel J Haisenleder Kurt T Barnhart G Wright Bates Rebecca Usadi Scott Lucidi Valerie Baker J C Trussell Stephen A Krawetz Peter Snyder Dana Ohl Nanette Santoro Esther Eisenberg Heping Zhang

BACKGROUND Clomiphene is the current first-line infertility treatment in women with the polycystic ovary syndrome, but aromatase inhibitors, including letrozole, might result in better pregnancy outcomes. METHODS In this double-blind, multicenter trial, we randomly assigned 750 women, in a 1:1 ratio, to receive letrozole or clomiphene for up to five treatment cycles, with visits to determine ...

2017
S.A. Amer J. Smith A. Mahran P. Fox A. Fakis

STUDY QUESTION Would letrozole as a primary ovulation induction agent generate better pregnancy rates than clomiphene citrate (CC) in subfertile women with anovulatory polycystic ovarian syndrome (PCOS)? SUMMARY ANSWER Participants receiving letrozole as a primary treatment achieved a significantly (P = 0.022) higher clinical pregnancy rate per patient (61.2%) compared to CC (43.0%). WHAT I...

2009
Alain Monnier

Aromatase inhibitors (AIs) are becoming more widely used than tamoxifen as adjuvant hormonal therapy for postmenopausal women (PMW) with early breast cancer (EBC). It is clear that these drugs offer important efficacy benefits over tamoxifen and differ from tamoxifen in their safety profile. The accepted strategies for adjuvant AI therapy include initial adjuvant treatment following surgery, sw...

2013
Snehal Gomes

A rapid and sensitive liquid chromatography tandem mass spectrometry method has been developed and validated for the simultaneous determination of metformin and letrozole in human plasma. The solid-phase extraction technique was used for the extraction of metformin and letrozole from human plasma. Anastrozole was used as the internal standard (IS). Chromatography was performed on a Hypurity C18...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید